Access cutting-edge parkinson's disease psychosis treatment through this clinical trial at a research site in San Antonio. Study-provided care at no cost to qualified participants.
Access parkinson's disease psychosis specialists in San Antonio at no cost
This study follows strict safety protocols and ethical guidelines
All study-related parkinson's disease psychosis treatment provided free
The primary objective of this study is to determine whether treatment with pimavanserin or quetiapine is associated with a greater improvement in psychosis when used in a routine clinical setting to treat hallucinations and/or delusions due to Parkinson's disease (PD) or dementia with Lewy bodies (DLB) - collectively referred to as Lewy body disease (LBD).
Sponsor: The University of Texas Health Science Center at San Antonio
Check if you qualify for this parkinson's disease psychosis clinical trial in San Antonio, TX
If you're searching for parkinson's disease psychosis treatment options in San Antonio, TX, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Antonio research site is actively enrolling participants for this clinical trial. You'll receive care from experienced parkinson's disease psychosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.